Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Terminated × 1-methyltryptophan × Clear all

Phase

Phase 1 2 Phase 2 1

Status

Completed 2 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Cyclophosphamide 139 Docetaxel 132 Carboplatin 129 Bevacizumab 129 pembrolizumab 124 Gemcitabine 116 Radiotherapy 115 Cisplatin 115 Paclitaxel 114 Capecitabine 101 Rituximab 99 Fluorouracil 93 Oxaliplatin 88 Nivolumab 76 Irinotecan 76 Leucovorin 74 Doxorubicin 71 Dexamethasone 68 Pemetrexed 66 fludarabine 62 Etoposide 60 fludarabine phosphate 57 Bortezomib 57 Erlotinib Hydrochloride 55 Methotrexate 52 Cytarabine 52 Cetuximab 52 Trastuzumab 48 Sorafenib 43 Prednisone 43

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03301636 2022-09-27

NLG2107

Lumos Pharma

Phase 2 Terminated

21 enrolled 11 charts

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡